Suchergebnisse - "Hjelmström, Peter"

PubPharm (45)

1

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2024

von Walsh, S. | Comer, S. | Zdovc, J. | +5

2

Oxycodone-related deaths in Sweden 2006-2018

enthalten in: Drug and alcohol dependence | 2022

von Fugelstad, A. | Ågren, G. | Ramstedt, M. | +2

3

Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine : A Randomized Clinical Trial

enthalten in: JAMA network open | 2021

von Lintzeris, N. | Dunlop, A. | Haber, P. | +9

CommentIn: JAMA Netw Open. 2021 May 3;4(5):e219708. - PMID 33970262

4

Readiness to try extended-released buprenorphine and related factors of interest: comparison between incarcerated and non-incarcerated subjects with opioid use disorder.

enthalten in: ResearchSquare.com | 2021

von CHAPPUY, M. | MEROUEH, F. | TROJAK, B. | +7

5

Determinants of interest in extended-released buprenorphine : A survey among 366 French patients treated with buprenorphine or methadone

enthalten in: Drug and alcohol dependence | 2021

von Rolland, B. | Trojak, B. | Nourredine, M. | +8

6

Methadone-related deaths among youth and young adults in Sweden 2006-15

enthalten in: Addiction (Abingdon, England) | 2021

von Fugelstad, A. | Bremberg, S. | Hjelmström, P. | +1

7

Factors of Interest in Extended-Release Buprenorphine : Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder

enthalten in: Patient preference and adherence | 2021

von Chappuy, M. | Meroueh, F. | Trojak, B. | +7

8

Methadone‐related deaths among youth and young adults in Sweden 2006–15

enthalten in: Addiction | 2021

von Fugelstad, A. | Bremberg, S. | Hjelmström, P. | +1

9

Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data

enthalten in: Drug development and industrial pharmacy | 2020

von Hjelmström, P. | Banke Nordbeck, E. | Tiberg, F.

10

Optimal dose of buprenorphine in opioid use disorder treatment : a review of pharmacodynamic and efficacy data

enthalten in: Drug development and industrial pharmacy | 2020

von Hjelmström, P. | Banke Nordbeck, E. | Tiberg, F.

1
2
3
4
5
Nächster »
[5]